Please login to the form below

Not currently logged in
Email:
Password:

Huntsworth appoints new CEO

Huntsworth Health has appointed Neil Matheson to the role of chief executive officer

Huntsworth Health has appointed Neil Matheson to the role of chief executive officer. Matheson was formerly chief executive of the company's North American operations; in his new role, he will lead the company's global operations. Sandy Royden continues as CEO of Huntsworth Health Europe.

Matheson's appointment follows the resignation of David Rowley who was CEO for eight years. Huntsworth Plc, acquired the company that Rowley founded, PBC, in 2001, providing the platform upon which Huntsworth Health was built. Rowley's leadership contributed significantly to the growth of the company, which employs more than 400 people worldwide and has amassed £50m in revenue.

Lord Chadlington, Chief Executive of Huntsworth Plc, said: "I am confident that Neil will build energetically on the Huntsworth Health platform… and lead us forward to the next stage in our global development." 

Matheson said: "I look forward to this opportunity to grow the Huntsworth Health family of best-in-class agency brands on a global scale. We have a fantastic executive team leading our brands and the talent within those brands is unparalleled."

"Sandy Royden and her talented team at Huntsworth Health Europe have done a fantastic job of building the business into a formidable force in European healthcare communications and I know they will continue to grow the European business as a critical part of our global family," added Matheson.

Huntsworth Health has offices in Philadelphia, New York, San Francisco, and London and has access to 71 offices in 30 countries through the Huntsworth plc global network.

7th October 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

International Childhood Cancer Day 2019
The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
Immuno-oncology in 2019: the rapid evolution continues
Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...
Mixing up Focus Groups
A nice spread of homogeneous participants in a focus groups are often a go to for reliable research outcomes but there's much to be said for mixing it up and...

Infographics